GALT Recombinant Monoclonal Antibody

Code CSB-RA993143A0HU
Size US$210
Order now
Image
  • Overlay Peak curve showing HepG2 cells stained with CSB-RA993143A0HU (red line) at 1:100. The cells were fixed in 4% formaldehyde and permeated by 0.2% TritonX-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*106cells) for 45min at 4℃. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG(H+L) at 1:200 dilution for 35min at 4℃.Control antibody (green line) was rabbit IgG (1ug/1*106cells) used under the same conditions. Acquisition of >10,000 events was performed.
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
GALT
Alternative Names
Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase), GALT
Species Reactivity
Human
Immunogen
A synthesized peptide derived from human GALT
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Monoclonal
Isotype
Rabbit IgG
Clone No.
19E1
Purification Method
Affinity-chromatography
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Rabbit IgG in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
Form
Liquid
Tested Applications
ELISA, FC
Recommended Dilution
Application Recommended Dilution
FC 1:50-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Description

The GALT recombinant monoclonal antibody was meticulously generated by CUSABIO through a rigorous procedure. Initially, B cells were isolated from the spleen of an immunized animal, with a synthesized peptide derived from human GALT used as the immunogen. Subsequently, RNA was extracted from the B cells and converted into cDNA through reverse transcription. Using the cDNA as a template, the gene encoding the GALT antibody was amplified with a degenerate primer and inserted into a vector. The recombinant vector was then introduced into host cells through transfection, enabling the production of the GALT recombinant monoclonal antibodies. Following expression, these antibodies were purified from the cell culture supernatant using affinity chromatography. The GALT recombinant monoclonal antibody's specific reactivity with human GALT protein was confirmed through ELISA and FC applications.

Usage
For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Plays an important role in galactose metabolism.
Gene References into Functions
  1. GALT mutation is associated with galactosemia. PMID: 29252199
  2. The mutational spectrum of the GALT gene in Greek galactosemia patients is presented for the first time. PMID: 28644047
  3. novel splicing mutation in GALT gene causing Galactosemia in Ecuadorian family PMID: 28450132
  4. 17 VUS (37%; 7 in ACADM, 9 in GALT, and 1 in PAH) were reclassified from uncertain (6 to benign or likely benign and 11 to pathogenic or likely pathogenic). We identified common types of missing information that would have helped make a definitive classification and categorized this information by ease and cost to obtain PMID: 27308838
  5. we present the 1.9 A resolution crystal structure of human GALT (hGALT) ternary complex, revealing a homodimer arrangement that contains a covalent uridylylated intermediate and glucose-1-phosphate in the active site, as well as a structural zinc-binding site, per monomer PMID: 27005423
  6. A novel noncoding homozygous GALT variant associated with asymptomatic galactosemia has been described in an infant of consanguineous heterozygous parents. PMID: 25920691
  7. Mutation activates a cryptic donor splice site, inducing an aberrant splicing of the GALT pre-mRNA, which in turn leads to a frameshift with inclusion of a premature stop codon. PMID: 25052314
  8. GALT activity in red blood cells of patients with galactosaemia PMID: 25268296
  9. Novel missense mutations identified in Italian galactosemic patients. PMID: 25592817
  10. In Korean population, novel GALT mutations were identified in the galactosemia patients different from those of other populations. PMID: 25124065
  11. suggests that GALT mutations are ethnic-specific and that galactosemia is a heterogeneous disorder at the molecular level PMID: 24045215
  12. In this report, we present GALT gene mutations in 56 cases of galactosemia from Turkey identified using DNA microarray resequencing. PMID: 23924834
  13. Data suggest that in classic galactosemia residual GALT activity (predicted from activity of recombinant GALT matching patient's mutation) correlates with reduced ovarian reserve (as indicted by biological marker, circulating anti-Mullerian hormone). PMID: 23690308
  14. HGALT requires a level of flexibility to function optimally and that altered folding is the underlying reason of impairment in all the variants tested here. PMID: 23583749
  15. The study determined the frequency of the two most common GALT mutations and their variants in Indian galactosemia patients. PMID: 22798028
  16. The novel GALT gene mutations included 6 missense mutations viz. Y89H, Q103R, P166A, S181F, K285R, R333L; one nonsense mutation, S307X and 3 silent mutations--Q103Q, K210K and H319H. PMID: 23022339
  17. Forty four novel variations in the GALT gene were identified, among them 27 nucleotide substitutions, in the French cohort of galactosemic patients. PMID: 22944367
  18. Mutations of the galactose-1-phosphate uridyltranseferase gene is associated with galactosemia. PMID: 22963887
  19. Duarte1 (D1) and D2 genotypes of GALT do not appear to play a role in the association between galactose intake, possible ovarian dysfunction, and the link with ovarian cancer PMID: 22749219
  20. 3 different GALT mutations viz. Q188R, N314D and S307X were found to be present in the family of a neonate diagnosed with galactosemia and having the heterozygote genotype Q188R/S307X. S307X is a novel GALT mutation linked to galactosemia. PMID: 21188552
  21. Results suggest that classical galactosaemia shows low allelic heterogeneity in Mexican patients. PMID: 18956253
  22. Congenital eye abnormalities and galactosemia were found in a family with Q188R and G1391A mutations. PMID: 20222886
  23. GALT deletion mutation carrier frequency was 1 in 127 (0.79%). PMID: 21059483
  24. live birth incidence of classical galactosemia in Estonia is 1:19.700 PMID: 20151200
  25. The simulated point mutations have a direct effect on the active site, or on the dimer assembly and stability, or on the monomer stability. PMID: 20008339
  26. no effect seen of N314D GALT genotype on risk of borderline or invasive ovarian cancer PMID: 11936817
  27. Data found no association between congenital absence of the uterus and vagina (CAUV) and the N314D allele of the galactose-1-phosphate uridyl transferase (GALT) gene. PMID: 12606594
  28. Increased expression of Galactosyltransferase is associated with ovarian cancer PMID: 12851678
  29. association of decreased galactose-1-phosphate uridyltransferase activity with idiopathic presenile cataract PMID: 14707519
  30. children and adolescents with galactosemia function generally within the low average IQ range and have less well-developed executive functions. PMID: 15506833
  31. No statistically significant differences were observed in the allele frequencies between the infertile women and control groups for GALT PMID: 15749517
  32. Nine novel mutations in the GALT gene associated with Classical galctosemia are described. PMID: 15841485
  33. No association of GALT mutations is found in 86 patients with idiopathic premature ovarian failure. PMID: 16009197
  34. We postulate that molecular link between defective GALT enzyme, which result in classic galactosemia and the cerebroside galactosyl transferase, responsible for galactosylation of cerebrosides, is dependent on concentrations of UDP-galactose. PMID: 16125333
  35. no relationship was found between ovarian failure and GALT polymorphisms in Indian women PMID: 16274605
  36. no significant differences between women carrying at least one N314D or Q188R GALT allele and controls in IVF outcomes measured: numbers of follicles and oocytes obtained; fertilization rates and percentage of Grade A embryos; and pregnancy rates. PMID: 16595241
  37. analysis of classical galactosaemia mutations in GALT1 in Spain and Portugal PMID: 17041746
  38. analysis of a patient with galactose-1-phosphate uridyltransferase mutations p.Q188R and p.R333W and galactose metabolite levels during breast-feeding [case report] PMID: 17143577
  39. Identified novel mutations in GALT gene using DNA testing. PMID: 17876724
  40. The R204X mutation severely compromises both expression and function of human GALT;T268N is one of a very small number of naturally occurring rare but neutral missense polymorphisms in human GALT. PMID: 18210213
  41. Synergistic effect of GALT and lactase mutations on cataract formation. PMID: 18454942
  42. 4 bp 5' deletion in GALT is a causal mutation in Duarte galactosemia. PMID: 19224951
  43. Galactose-1-phosphate uridyl transferase deficiency is not associated with Mullerian aplasia in Dutch patients PMID: 19646668

Show More

Hide All

Involvement in disease
Galactosemia (GALCT)
Protein Families
Galactose-1-phosphate uridylyltransferase type 1 family
Database Links

HGNC: 4135

OMIM: 230400

KEGG: hsa:2592

STRING: 9606.ENSP00000368119

UniGene: Hs.522090

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*